Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | APEX1 | P27695 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | TUBB4A | P04350 | 4/20 | 0.56 |
| ▸ | TUBB | P07437 | 4/20 | 0.56 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.56 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.56 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.56 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.56 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29520102 | 0.85 | ALDH1A1 (0.72) | GAACYP3A4TSHRNFKB1ALOX15 | |
| SCHEMBL917723 | 0.85 | ALDH1A1 (0.72) | GAACYP3A4TSHRNFKB1ALOX15 | |
| SCHEMBL909947 | 0.84 | CYP1A2 (0.63) | GAACYP3A4CYP1A2TSHRNFKB1 | |
| SCHEMBL30690114 | 0.84 | CYP1A2 (0.63) | GAACYP3A4CYP1A2TSHRNFKB1 | |
| Chavibetol SCHEMBL901503 | 0.84 | ALOX5 (0.75) | GAACYP3A4CYP1A2TSHRNFKB1 | |
| Chavibetol SCHEMBL29752081 | 0.84 | ALOX5 (0.75) | GAACYP3A4CYP1A2TSHRNFKB1 | |
| SCHEMBL30644304 | 0.82 | ALDH1A1 (0.69) | GAACYP3A4CYP1A2TSHRALDH1A1 | |
| SCHEMBL557409 | 0.82 | ALDH1A1 (0.69) | GAACYP3A4CYP1A2TSHRALDH1A1 | |
| SCHEMBL1360251 | 0.82 | CYP3A4 (0.56) | GAACYP3A4CYP1A2TSHRNFKB1 | |
| SCHEMBL620909 | 0.81 | CYP1A2 (0.62) | GAACYP3A4CYP1A2TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119306789-B | Preparation method of Edwan sweet | 山东奔月生物科技股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119306789-A | Preparation method of Edwan sweet | 山东奔月生物科技股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| WO-2024194018-A1 | METHOD FOR PRODUCING CORYTUBERINE AND SALUTARIDINE | Universität Graz (AT) | 2024-09-26 | — | — | WO | disclosed |
| EP-4431612-A1 | PROCESS FOR THE PREPARATION OF CORORYLOURIN AND SALUTARIDINE | Universität Graz (AT) | 2024-09-18 | — | — | EP | disclosed |
| CN-116535304-B | Erianin analogue, and synthetic method and application thereof | 中国科学院成都生物研究所 | 2024-07-19 | — | — | CN | disclosed |
| CN-116535304-A | Erianin analogue, and synthetic method and application thereof | 中国科学院成都生物研究所 | 2023-08-04 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| WO-2019201865-A1 | SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES | MASARYKOVA UNIVERZITA (CZ) | 2019-10-24 | — | — | WO | disclosed |
| EP-3215152-A1 | SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP) | The University of Kansas (US) | 2017-09-13 | — | — | EP | disclosed |
| US-9745280-B2 | Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient | SNU R&DB FOUNDATION (KR) | 2017-08-29 | — | — | US | disclosed |
| WO-2014130582-A2 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | SENOMYX, INC. (US) | 2014-08-28 | — | — | WO | disclosed |
| WO-2012125533-A1 | 3-BENZYLOXYPHENYLOXOACETIC ACID COMPOUNDS FOR REDUCING URIC ACID | WELLSTAT THERAPEUTICS CORPORATION (US) | 2012-09-20 | — | — | WO | disclosed |
| WO-2012075048-A2 | HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2012-06-07 | — | — | WO | disclosed |
| EP-2231669-A1 | PHOSPHODIESTERASE INHIBITORS | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services (US) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009089027-A1 | PHOSPHODIESTERASE INHIBITORS | GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICE, NATIONAL INSTITUTES OF HEALTH (US) | 2009-07-16 | — | — | WO | disclosed |
| WO-2009012375-A2 | SQUARATE KINASE INHIBITORS | WYETH (US) | 2009-01-22 | — | — | WO | disclosed |
| EP-1991531-A1 | CINNOLINE AND QUINOXALINE DERIVATES AS PHOSPHODIESTERASE 10 INHIBITORS | Amgen Inc. (US) | 2008-11-19 | — | — | EP | disclosed |
| WO-2007100880-A1 | CINNOLINE AND QUINAZOLINE DERIVATES AS PHOSPHODIESTERASE 10 INHIBITORS | AMGEN INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-20020065309-A1 | Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists | AFFYMAX, INC. | 2002-05-30 | — | — | US | disclosed |
| WO-2002011732-A1 | NOVEL BICYCLIC AND TRICYCLIC PYRROLIDINE DERIVATIVES AS GNRH ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2002-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065309-A1 | Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists | GNRHR, FSHR, LHCGR | GAA 3548/4885CYP3A4 2787/4885CYP1A2 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.